11.10.2017
- Swiss specialty chemicals company Lonza has acquired Shire’s clinical-stage mammalian manufacturing site in Hayward, California, USA, boosting its cGMP capacity and supplementing...
11.08.2017
- Ireland-domiciled drugmaker Shire is considering splitting off its neuroscience division into a separate, publicly listed company. The move, revealed during its second-quarter...
26.07.2017
- Shire has obtained exclusive worldwide rights from Novimmune for a bi-specific antibody that is currently in pre-clinical development for treating patients with the blood disorders...
06.01.2017
- Ireland-headquartered drugmaker Shire Pharmaceuticals has sold its messenger RNA (mRNA) therapy platform MRT to US firm RaNA Therapeutics. Financial details were not revealed, but...
10.11.2016
- Shares in major globally active pharmaceutical producers rose by as much as 11% on the news that Donald Trump had won the Nov. 8 election as president of the United States. The...
12.05.2016
- The good old days are gone — at least with regard to simplicity in business life. This is particularly true for life sciences companies affected by trends increasing the complexity...
20.04.2016
- Ireland-based drugmaker Shire has announced an investment of $400 million to expand its global biotechnology manufacturing capacity in County Meath over the next four years. The...
12.01.2016
- In a deal worth around $32 billion, Irish drug maker Shire – headquartered in Dublin but managed from Boston, Massachusetts – has agreed a takeover of US biopharmaceutical company...
